window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 1, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Chronic diseases,Clinical Development,Clinical studies,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    Amorphical reports positive interim results from ongoing Crohn’s disease trial

    Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]

    October 1, 2025
  • Biologics & Biosimilars,Clinical Development,Clinical studies,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    PACE launches third funding round to tackle antimicrobial resistance and support innovative therapeutics

    PACE (Pathways to Antimicrobial Clinical Efficacy) has launched its third [...]

    October 1, 2025
  • Biomanufacturing,Biotech,Drug Development,Research & Development,Technology and platforms

    Abselion extends Amperia platform with Protein G kit for broader antibody quantification

    Abselion has expanded its Amperia benchtop platform with a new [...]

    September 29, 2025
  • Biotech,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    Cidara Therapeutics expands and accelerates phase 3 trial of CD388 for flu prevention

    Cidara Therapeutics has announced an expanded and accelerated Phase 3 [...]

    September 29, 2025
  • Biomanufacturing,Clinical Development,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Research & Development

    Crown Bioscience opens new model development center in North Carolina to expand US oncology research

    Crown Bioscience has opened a model development center in Kannapolis, [...]

    September 29, 2025
  • Biomanufacturing,Biotech,Research & Development,Supply Chain & Logistics,Technology and platforms

    Miebach Consulting doubles Oxfordshire footprint to support life sciences supply chains at Abingdon Science Park

    Categories: Biomanufacturing, Biotech, Supply Chain & Logistics, Technology and platforms, [...]

    September 26, 2025
  • Artificial Intelligence,Biotech,Clinical Development,Data Management,Research & Development

    Pistoia Alliance survey shows AI adoption surging in life sciences labs, but skills gaps remain a challenge

    The Pistoia Alliance, a global not-for-profit advocating collaboration in life [...]

    September 26, 2025
  • Biomanufacturing,Biotech,Cell & Gene Therapy,Clinical Development,Pharmaceuticals and therapeutics,Research & Development

    BioGrad unveils state-of-the-art Liverpool bio-manufacturing centre to drive cell and gene therapy growth in the North

    BioGrad has announced plans for a new Centre of Bio-Manufacturing [...]

    September 26, 2025
  • Biotech,Cell & Gene Therapy,Clinical Development,Oncology,Precision medicine,Research & Development

    Inaphaea BioLabs boosts precision oncology with new partnerships, advanced tumour models, and digital patient avatars

    Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

    September 26, 2025
  • Biologics & Biosimilars,Biotech,Partnerships & Funding,Rare Diseases,Research & Development

    DEBRA Research and Nonsense Therapeutics launch ReadOn Therapeutics to target epidermolysis bullosa

    DEBRA Research gGmbH, a global non-profit dedicated to advancing research [...]

    September 26, 2025
Previous171819Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • BridgeBio submits FDA NDA for BBP-418 in limb-girdle muscular dystrophy type 2I/R9
    Categories: Clinical Development, Drug Development, FDA, Genetic Diseases, Orphan drugs, Pharmaceuticals and therapeutics, Rare Diseases
  • Symeres and Ambagon partner on molecular glue research in colorectal cancer
    Categories: Drug discovery, Oncology, Partnerships & Funding, Research & Development, Startups and innovations, Technology and platforms
  • Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly
    Categories: Artificial Intelligence, Drug discovery, Partnerships & Funding
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top